 | • レポートコード：MRC2-11QY03900 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はナノ粒子のグローバル市場について調査・分析したレポートです。種類別（リポソーム、高分子結合薬、高分子ナノ粒子、デンドリマー、無機ナノ粒子、その他）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ナノ粒子の競争状況、市場シェア ・世界のナノ粒子市場：種類別市場規模 2015年-2020年（リポソーム、高分子結合薬、高分子ナノ粒子、デンドリマー、無機ナノ粒子、その他） ・世界のナノ粒子市場：種類別市場規模予測 2021年-2026年（リポソーム、高分子結合薬、高分子ナノ粒子、デンドリマー、無機ナノ粒子、その他） ・世界のナノ粒子市場：用途別市場規模 2015年-2020年（病院、外来手術センター、診断センター） ・世界のナノ粒子市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、診断センター） ・北米のナノ粒子市場分析：米国、カナダ ・ヨーロッパのナノ粒子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのナノ粒子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のナノ粒子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのナノ粒子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Gilead Sciences、Johnson & Johnson、Amgen、Sigma-Tau Pharmaceuticals、Abraxis Biosciences、Nano Interface Technology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A nanoparticle is an individual molecule that behaves as a whole unit in terms of its transport and properties. The particle size of nanoparticles is 1 to 100 nanometers. The nanoparticles are further classified according to diameter as ultrafine particles (between 1 and 100 nanometers in size), fine particles (between 100 and 2,500 nanometers), and coarse particles (2,500 and 10,000 nanometers).
Due to a wide variety of potential applications in biomedical, optical, and electronic fields the nanoparticle research is currently an area of intense scientific research. There are various applications of nanoparticles in drug delivery. Nanotechnology is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. The expanding medical diagnostics industry, increasing growth in advance healthcare technology and high advantages in medicinal imaging applications are some of the key drivers that are fuelling the growth of global nanoparticles market.
Market Analysis and Insights: Global Nanoparticles Market
The global Nanoparticles market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Nanoparticles Scope and Market Size
Nanoparticles market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nanoparticles market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
Gilead Sciences
Johnson & Johnson
Amgen
Sigma-Tau Pharmaceuticals
Abraxis Biosciences
Nano Interface Technology
…
Market segment by Type, the product can be split into
Liposomes
Polymer-Conjugated Drugs
Polymeric Nanoparticles
Dendrimers
Inorganic Nanoparticles
Others
Market segment by Application, split into
Hospitals
Ambulatory Surgery Centers
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nanoparticles Revenue
1.4 Market by Type
1.4.1 Global Nanoparticles Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liposomes
1.4.3 Polymer-Conjugated Drugs
1.4.4 Polymeric Nanoparticles
1.4.5 Dendrimers
1.4.6 Inorganic Nanoparticles
1.4.7 Others
1.5 Market by Application
1.5.1 Global Nanoparticles Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgery Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Nanoparticles Market Perspective (2015-2026)
2.2 Global Nanoparticles Growth Trends by Regions
2.2.1 Nanoparticles Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nanoparticles Historic Market Share by Regions (2015-2020)
2.2.3 Nanoparticles Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nanoparticles Market Growth Strategy
2.3.6 Primary Interviews with Key Nanoparticles Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nanoparticles Players by Market Size
3.1.1 Global Top Nanoparticles Players by Revenue (2015-2020)
3.1.2 Global Nanoparticles Revenue Market Share by Players (2015-2020)
3.1.3 Global Nanoparticles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nanoparticles Market Concentration Ratio
3.2.1 Global Nanoparticles Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nanoparticles Revenue in 2019
3.3 Nanoparticles Key Players Head office and Area Served
3.4 Key Players Nanoparticles Product Solution and Service
3.5 Date of Enter into Nanoparticles Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nanoparticles Historic Market Size by Type (2015-2020)
4.2 Global Nanoparticles Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Nanoparticles Market Size by Application (2015-2020)
5.2 Global Nanoparticles Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Nanoparticles Market Size (2015-2020)
6.2 Nanoparticles Key Players in North America (2019-2020)
6.3 North America Nanoparticles Market Size by Type (2015-2020)
6.4 North America Nanoparticles Market Size by Application (2015-2020)
7 Europe
7.1 Europe Nanoparticles Market Size (2015-2020)
7.2 Nanoparticles Key Players in Europe (2019-2020)
7.3 Europe Nanoparticles Market Size by Type (2015-2020)
7.4 Europe Nanoparticles Market Size by Application (2015-2020)
8 China
8.1 China Nanoparticles Market Size (2015-2020)
8.2 Nanoparticles Key Players in China (2019-2020)
8.3 China Nanoparticles Market Size by Type (2015-2020)
8.4 China Nanoparticles Market Size by Application (2015-2020)
9 Japan
9.1 Japan Nanoparticles Market Size (2015-2020)
9.2 Nanoparticles Key Players in Japan (2019-2020)
9.3 Japan Nanoparticles Market Size by Type (2015-2020)
9.4 Japan Nanoparticles Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Nanoparticles Market Size (2015-2020)
10.2 Nanoparticles Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nanoparticles Market Size by Type (2015-2020)
10.4 Southeast Asia Nanoparticles Market Size by Application (2015-2020)
11 India
11.1 India Nanoparticles Market Size (2015-2020)
11.2 Nanoparticles Key Players in India (2019-2020)
11.3 India Nanoparticles Market Size by Type (2015-2020)
11.4 India Nanoparticles Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Nanoparticles Market Size (2015-2020)
12.2 Nanoparticles Key Players in Central & South America (2019-2020)
12.3 Central & South America Nanoparticles Market Size by Type (2015-2020)
12.4 Central & South America Nanoparticles Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Nanoparticles Introduction
13.1.4 Novartis Revenue in Nanoparticles Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Details
13.2.2 Gilead Sciences Business Overview
13.2.3 Gilead Sciences Nanoparticles Introduction
13.2.4 Gilead Sciences Revenue in Nanoparticles Business (2015-2020)
13.2.5 Gilead Sciences Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Nanoparticles Introduction
13.3.4 Johnson & Johnson Revenue in Nanoparticles Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen Nanoparticles Introduction
13.4.4 Amgen Revenue in Nanoparticles Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Sigma-Tau Pharmaceuticals
13.5.1 Sigma-Tau Pharmaceuticals Company Details
13.5.2 Sigma-Tau Pharmaceuticals Business Overview
13.5.3 Sigma-Tau Pharmaceuticals Nanoparticles Introduction
13.5.4 Sigma-Tau Pharmaceuticals Revenue in Nanoparticles Business (2015-2020)
13.5.5 Sigma-Tau Pharmaceuticals Recent Development
13.6 Abraxis Biosciences
13.6.1 Abraxis Biosciences Company Details
13.6.2 Abraxis Biosciences Business Overview
13.6.3 Abraxis Biosciences Nanoparticles Introduction
13.6.4 Abraxis Biosciences Revenue in Nanoparticles Business (2015-2020)
13.6.5 Abraxis Biosciences Recent Development
13.7 Nano Interface Technology
13.7.1 Nano Interface Technology Company Details
13.7.2 Nano Interface Technology Business Overview
13.7.3 Nano Interface Technology Nanoparticles Introduction
13.7.4 Nano Interface Technology Revenue in Nanoparticles Business (2015-2020)
13.7.5 Nano Interface Technology Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Nanoparticles Key Market Segments
Table 2. Key Players Covered: Ranking by Nanoparticles Revenue
Table 3. Ranking of Global Top Nanoparticles Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nanoparticles Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liposomes
Table 6. Key Players of Polymer-Conjugated Drugs
Table 7. Key Players of Polymeric Nanoparticles
Table 8. Key Players of Dendrimers
Table 9. Key Players of Inorganic Nanoparticles
Table 10. Key Players of Others
Table 11. Global Nanoparticles Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Nanoparticles Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Nanoparticles Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Nanoparticles Market Share by Regions (2015-2020)
Table 15. Global Nanoparticles Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Nanoparticles Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Nanoparticles Market Growth Strategy
Table 21. Main Points Interviewed from Key Nanoparticles Players
Table 22. Global Nanoparticles Revenue by Players (2015-2020) (Million US$)
Table 23. Global Nanoparticles Market Share by Players (2015-2020)
Table 24. Global Top Nanoparticles Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanoparticles as of 2019)
Table 25. Global Nanoparticles by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Nanoparticles Product Solution and Service
Table 28. Date of Enter into Nanoparticles Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Nanoparticles Market Size by Type (2015-2020) (Million US$)
Table 31. Global Nanoparticles Market Size Share by Type (2015-2020)
Table 32. Global Nanoparticles Revenue Market Share by Type (2021-2026)
Table 33. Global Nanoparticles Market Size Share by Application (2015-2020)
Table 34. Global Nanoparticles Market Size by Application (2015-2020) (Million US$)
Table 35. Global Nanoparticles Market Size Share by Application (2021-2026)
Table 36. North America Key Players Nanoparticles Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Nanoparticles Market Share (2019-2020)
Table 38. North America Nanoparticles Market Size by Type (2015-2020) (Million US$)
Table 39. North America Nanoparticles Market Share by Type (2015-2020)
Table 40. North America Nanoparticles Market Size by Application (2015-2020) (Million US$)
Table 41. North America Nanoparticles Market Share by Application (2015-2020)
Table 42. Europe Key Players Nanoparticles Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Nanoparticles Market Share (2019-2020)
Table 44. Europe Nanoparticles Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Nanoparticles Market Share by Type (2015-2020)
Table 46. Europe Nanoparticles Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Nanoparticles Market Share by Application (2015-2020)
Table 48. China Key Players Nanoparticles Revenue (2019-2020) (Million US$)
Table 49. China Key Players Nanoparticles Market Share (2019-2020)
Table 50. China Nanoparticles Market Size by Type (2015-2020) (Million US$)
Table 51. China Nanoparticles Market Share by Type (2015-2020)
Table 52. China Nanoparticles Market Size by Application (2015-2020) (Million US$)
Table 53. China Nanoparticles Market Share by Application (2015-2020)
Table 54. Japan Key Players Nanoparticles Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Nanoparticles Market Share (2019-2020)
Table 56. Japan Nanoparticles Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Nanoparticles Market Share by Type (2015-2020)
Table 58. Japan Nanoparticles Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Nanoparticles Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Nanoparticles Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Nanoparticles Market Share (2019-2020)
Table 62. Southeast Asia Nanoparticles Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Nanoparticles Market Share by Type (2015-2020)
Table 64. Southeast Asia Nanoparticles Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Nanoparticles Market Share by Application (2015-2020)
Table 66. India Key Players Nanoparticles Revenue (2019-2020) (Million US$)
Table 67. India Key Players Nanoparticles Market Share (2019-2020)
Table 68. India Nanoparticles Market Size by Type (2015-2020) (Million US$)
Table 69. India Nanoparticles Market Share by Type (2015-2020)
Table 70. India Nanoparticles Market Size by Application (2015-2020) (Million US$)
Table 71. India Nanoparticles Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Nanoparticles Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Nanoparticles Market Share (2019-2020)
Table 74. Central & South America Nanoparticles Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Nanoparticles Market Share by Type (2015-2020)
Table 76. Central & South America Nanoparticles Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Nanoparticles Market Share by Application (2015-2020)
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Product
Table 81. Novartis Revenue in Nanoparticles Business (2015-2020) (Million US$)
Table 82. Novartis Recent Development
Table 83. Gilead Sciences Company Details
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Product
Table 86. Gilead Sciences Revenue in Nanoparticles Business (2015-2020) (Million US$)
Table 87. Gilead Sciences Recent Development
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Product
Table 91. Johnson & Johnson Revenue in Nanoparticles Business (2015-2020) (Million US$)
Table 92. Johnson & Johnson Recent Development
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Product
Table 96. Amgen Revenue in Nanoparticles Business (2015-2020) (Million US$)
Table 97. Amgen Recent Development
Table 98. Sigma-Tau Pharmaceuticals Company Details
Table 99. Sigma-Tau Pharmaceuticals Business Overview
Table 100. Sigma-Tau Pharmaceuticals Product
Table 101. Sigma-Tau Pharmaceuticals Revenue in Nanoparticles Business (2015-2020) (Million US$)
Table 102. Sigma-Tau Pharmaceuticals Recent Development
Table 103. Abraxis Biosciences Company Details
Table 104. Abraxis Biosciences Business Overview
Table 105. Abraxis Biosciences Product
Table 106. Abraxis Biosciences Revenue in Nanoparticles Business (2015-2020) (Million US$)
Table 107. Abraxis Biosciences Recent Development
Table 108. Nano Interface Technology Company Details
Table 109. Nano Interface Technology Business Overview
Table 110. Nano Interface Technology Product
Table 111. Nano Interface Technology Revenue in Nanoparticles Business (2015-2020) (Million US$)
Table 112. Nano Interface Technology Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanoparticles Market Share by Type: 2020 VS 2026
Figure 2. Liposomes Features
Figure 3. Polymer-Conjugated Drugs Features
Figure 4. Polymeric Nanoparticles Features
Figure 5. Dendrimers Features
Figure 6. Inorganic Nanoparticles Features
Figure 7. Others Features
Figure 8. Global Nanoparticles Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgery Centers Case Studies
Figure 11. Diagnostic Centers Case Studies
Figure 12. Nanoparticles Report Years Considered
Figure 13. Global Nanoparticles Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Nanoparticles Market Share by Regions: 2020 VS 2026
Figure 15. Global Nanoparticles Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Nanoparticles Market Share by Players in 2019
Figure 18. Global Top Nanoparticles Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanoparticles as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Nanoparticles Revenue in 2019
Figure 20. North America Nanoparticles Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Nanoparticles Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Nanoparticles Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Nanoparticles Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Nanoparticles Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Nanoparticles Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Nanoparticles Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
高分子ナノ粒子の世界市場（～2026年） Polymer nanoparticles have characteristics such as high electrical conductivity, enhanced dimensional stability, and high heat resistance. Polymer nanoparticles are widely used in compact electronics manufacturing. North America has become a major consumer of polymer nanoparticles, and is expected t…- 白金ナノ粒子の世界市場（～2026年） Platinum nanoparticles are typically in the form of suspensions or colloids of submicron sized particles of platinum in a liquid. The global platinum nanoparticle market is expected to grow due to increasing research and development expenditures for nanomaterials in the automotive, medical and chemi…
- 磁性ナノ粒子の世界市場（～2026年） Nanoparticles are particles that have at least one dimension in a nano scale. They have properties different from their own macro scale properties. Magnetic nanoparticles are particles whose properties can be manipulated upon exposure to a magnetic field. For energy storage applications, Fe3O4 and o…
- 酸化セリウムナノ粒子の世界市場（～2026年） Cerium oxide nanoparticles are rare earth oxide metal, which are utilized in various applications such as, in energy storage products, personal care products, also act as polishing agent for glass mirrors, owing to its versatile properties and electronic configuration. However, the utilization of ce…
- 金属・金属酸化物ナノ粒子の世界市場（～2026年） Market Analysis and Insights: Global Metal & Metal Oxide Nanoparticles Market The global Metal & Metal Oxide Nanoparticles market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metal & Metal Oxide Nanoparticles Scope and Mar…